WJ460 is an inhibitor of myoferlin (MYOF) which exerts anti-metastatic activity in the nanomolar range in breast cancer cells. References: Zhang T, Li J, He Y, Yang F, Hao Y, Jin W, Wu J, Sun Z, Li Y, Chen Y, Yi Z, Liu M. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer. Nat Commun. 2018 Sep 13;9(1):3726. doi: 10.1038/s41467-018-06179-0. PubMed PMID: 30213946; PubMed Central PMCID: PMC6137146.

纯度：≥98%

CAS：1415251-36-3